Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Huare Biotechnology is a life sciences company based in Wuhan, China, specializing in the development and production of high-quality biological reagents for research and diagnostic applications. The company offers an extensive portfolio of products, including recombinant proteins, cytokines, monoclonal and polyclonal antibodies, and ELISA kits, which serve as critical tools for academic research and pharmaceutical drug discovery. Beyond its product catalog, Wuhan Huare provides contract research services such as custom protein expression in various systems and antibody development. The firm operates out of the Wuhan Optical Valley Biological Medicine Park and caters to a global market including biotechnology companies and diagnostic laboratories. Its core focus areas include oncology, immunology, and cell signaling research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Huare Biotechnology.